NOVONIX Ltd — Investor Presentation 2017

Apr 6, 2017

==> picture [320 x 24] intentionally omitted <==

Downstream Integration Update

==> picture [237 x 111] intentionally omitted <==

Presentation to General Meeting of Shareholders 7 April 2017

==> picture [250 x 34] intentionally omitted <==

• Downstream integration into high value high growth battery materials market

• Acquisition of leading battery anode materials and battery cell testing technologies

• Production joint venture with leading USA-based anode materials development company – Coulometrics

• Acquisition of two-thirds interest in leading battery testing equipment and services company – NOVONIX

==> picture [842 x 19] intentionally omitted <==

----- Start of picture text -----

7 April 2017 ASX: GRA 1
----- End of picture text -----

==> picture [320 x 24] intentionally omitted <==

Important notice

No reliance

To the maximum extent permitted by law, the information contained in this presentation is given without any liability whatsoever being accepted by Graphitecorp Limited ( GRA ) or any of its related bodies corporate or their respective directors, officers, employees, advisors and agents ( Relevant Parties ). The information contained in this presentation is not intended to constitute legal, tax or accounting advice or opinion. No representation or warranty, expressed or implied, is made as to the accuracy, completeness or thoroughness of the information, whether as to the past or future. Recipients of the document must make their own independent investigations, consideration and evaluation.

Limited disclosure

This presentation contains summary information about GRA and its activities which is current at the date of this presentation. The information in this presentation is of a general nature. The presentation does not purport to contain all the information that a prospective investor may require in evaluating a possible investment in GRA nor does it contain all the information which would be required in a disclosure document prepared in accordance with the requirements of the Corporations Act 2001 (Cth) and should not be used in isolation as a basis to invest in GRA. It should be read in conjunction with GRA’s other periodic and continuous disclosure announcements lodged with the Australian Securities Exchange, which are available at www.asx.com.au.

Seek your own advice

In providing this presentation, GRA has not considered the objectives, financial position or needs of the recipient. The recipient should consult with its own legal, tax or accounting advisers as to the accuracy and application of the information contained herein, and conduct its own due diligence and other enquiries in relation to such information and any investment in GRA and the recipient’s objectives, financial position or needs.

No offer to acquire GRA shares

The information in this presentation is not an offer or recommendation to purchase or subscribe for securities in GRA in any jurisdiction in which it would be unlawful. The distribution of this presentation in jurisdictions outside of Australia and New Zealand may be restricted by law and you should observe any such restrictions. In particular, this presentation does not constitute any part of any offer to sell, or the solicitation of an offer to buy, any securities in the United States or to, or for the account or benefit of, any person in the United States. GRA securities have not been, and will not be, registered under the US Securities Act of 1933 ( US Securities Act ) or the securities laws of any state or other jurisdiction of the United States, and may not be offered or sold in the United States except in transactions exempt from, or not subject to, the registration requirements of the US Securities Act and applicable US state securities laws.

Forward‐looking statements

Statements and material contained in this presentation, particularly those regarding possible or assumed future performance, industry growth or other trend projections are, or may be, forward looking statements. Such statements relate to future events and expectations and, as such, involve known and unknown risks and uncertainties. Graphs used in the presentation (including data used in the graphs) are sourced from third parties and GRA has not independently verified the information. Although reasonable care has been taken to ensure that the facts stated in this presentation are accurate and that the opinions expressed are fair and reasonable, no reliance can be placed for any purpose whatsoever on the information contained in this document or on its completeness. Actual results and developments may differ materially from those expressed or implied by these forward looking statements depending on a variety of factors. Nothing in this Presentation should be construed as either an offer to sell or a solicitation of an offer to buy or sell shares in any jurisdiction.

Currency

All references to ‘$’ are to Australian currency (AUD) unless otherwise noted.

==> picture [842 x 19] intentionally omitted <==

----- Start of picture text -----

7 April 2017 ASX: GRA 2
----- End of picture text -----

==> picture [320 x 24] intentionally omitted <==

RECAP

Institutional placement of loan notes to raise AUD $15.5 million

• GRA to establish PUREgraphite , an exclusive joint venture with Coulometrics (Dr Edward Buiel), a recognised leader in battery materials development and testing and, separately, acquire a two‐thirds interest in NOVONIX , a leading battery testing equipment and services company (subject to pre‐emptive rights)

• GRA has commitments to place AUD $15.5 million of convertible notes to institutional and sophisticated investors

• Settlement will occur in two tranches (second tranche subject to shareholder approval)

• GRA’s directors and their families have supported the placement (AUD $660,000 subscription)

Settlement ‐ 7 March 2017 – tranche 1 settlement ($7.7 million) ‐ 7 April 2017 ‐ shareholder meeting (indicative) ‐ 10 April 2017 – tranche 2 settlement ($7.8 million)

Use of funds AUD (M) Contribution to PUREgraphite joint venture ‐ acquire battery anode materials technology and exclusivity from Coulometrics (Dr Edward Buiel) $6.7 Contribution to PUREgraphite joint venture ‐ development capital $4.0 Acquisition of two‐thirds interest in battery testing equipment company – NOVONIX and key personnel retention costs (Dr Chris Burns and Dr David Stevens) $3.0 Working capital and fund raising costs $1.8 TOTAL $15.5

==> picture [842 x 19] intentionally omitted <==

----- Start of picture text -----

7 April 2017 ASX: GRA 3
----- End of picture text -----

UPDATE

==> picture [320 x 24] intentionally omitted <==

==> picture [221 x 110] intentionally omitted <==

• The PUREgraphite exclusive joint venture with Coulometrics established and operating in USA

• Meetings in the USA to refine the strategic and operational plans for PUREgraphite

• PUREgraphite CEO presents at the 34[th] International Battery Seminar in Florida, USA

• Equipment selection and supply arrangements nearing completion with orders expected to be placed this month

• Synthetic and natural graphite sourcing processes underway

==> picture [842 x 19] intentionally omitted <==

----- Start of picture text -----

7 April 2017 ASX: GRA 4
----- End of picture text -----

UPDATE

==> picture [320 x 24] intentionally omitted <==

==> picture [259 x 33] intentionally omitted <==

• Acquisition of two-thirds interest in NOVONIX confirmed with CATL waiving pre-emptive rights

• Meetings and factory visit with CATL in China

• Meetings in Canada to refine the strategic and operational plans for NOVONIX

• CATL supply agreement with NOVONIX to continue

• NOVONIX exhibition at the 34[th] International Battery Seminar in Florida, USA

• NOVONIX to establish high precision battery testing center in USA co-located with PUREgraphite and Coulometrics

==> picture [842 x 19] intentionally omitted <==

----- Start of picture text -----

7 April 2017 ASX: GRA 5
----- End of picture text -----

UPDATE

==> picture [320 x 24] intentionally omitted <==

==> picture [318 x 83] intentionally omitted <==

• Mining License application review process underway

• Environmental Authority application review process underway

• Land stakeholder meetings underway

• Bulk sample approval process underway

• Pilot processing programs underway

• Process plant options study underway including locations in Cloncurry and use of existing mine facilities

==> picture [842 x 19] intentionally omitted <==

----- Start of picture text -----

7 April 2017 ASX: GRA 6
----- End of picture text -----

==> picture [290 x 144] intentionally omitted <==

==> picture [320 x 24] intentionally omitted <==

==> picture [291 x 42] intentionally omitted <==

Short video ‐ Dr Edward Buiel ‐ CEO https://www.youtube.com/watch?v=6vKTixWMddQ

==> picture [150 x 141] intentionally omitted <==

Short video ‐ Dr Chris Burns ‐ CEO https://www.youtube.com/watch?v=UiEjv‐uoiB4

==> picture [125 x 137] intentionally omitted <==

Link to Coulometrics website: http://coulometrics.com/

Link to NOVONIX website: http://www.novonix.ca/

==> picture [842 x 19] intentionally omitted <==

----- Start of picture text -----

7 April 2017 ASX: GRA 7
----- End of picture text -----

==> picture [320 x 24] intentionally omitted <==

==> picture [229 x 30] intentionally omitted <==

CUSTOMERS

==> picture [307 x 105] intentionally omitted <==

GLOBAL USA AUTO/EV MAKERS

==> picture [165 x 125] intentionally omitted <==

==> picture [249 x 71] intentionally omitted <==

==> picture [249 x 70] intentionally omitted <==

==> picture [176 x 103] intentionally omitted <==

==> picture [225 x 94] intentionally omitted <==

GLOBAL MEDICAL DEVICE MAKER

==> picture [842 x 19] intentionally omitted <==

----- Start of picture text -----

7 April 2017 ASX: GRA 8
----- End of picture text -----

==> picture [842 x 475] intentionally omitted <==

----- Start of picture text -----

MINING MICRONIZING
CRUSHING SPHERONIZING
SLURRY MAKING
GRINDING CLASSIYFING
ANODE COATING
FLOTATION
PURIFYING
CALENDARING
FILTERING
COATING
operated by: SLITTING
DRYING
BLENDING
WINDING
CLASSIFYING
ANODE MTL
TAB WELDING
USD $10,000 ‐ $20,000 / t
CONCENTRATE
CELL ASSEMBLY
USD $600 ‐ $2,000 / t
CELL TESTING
BATTERY MAKER
INTERACTIVE
9
4/7/2017 CONFIDENTIAL DOCUMENT 9
----- End of picture text -----

==> picture [320 x 24] intentionally omitted <==

Philip St Baker Managing Director Graphitecorp Limited

GPO Box 525 Brisbane QLD 4001 AUSTRALIA

+61 0438 173 330 phil@graphitecorp.com.au

Greg Baynton Executive Director Graphitecorp Limited GPO Box 525 Brisbane QLD 4001 AUSTRALIA +61 414 970 677 greg@graphitecorp.com.au

==> picture [842 x 19] intentionally omitted <==

----- Start of picture text -----

7 April 2017 ASX: GRA 10
----- End of picture text -----